angiotensin ii has been researched along with Bone Diseases, Metabolic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Diao, TY; Gu, SS; Pan, H; Wong, MS; Zhang, FY; Zhang, Y | 1 |
| Morishita, R; Nakagami, H; Shimizu, H | 1 |
2 other study(ies) available for angiotensin ii and Bone Diseases, Metabolic
| Article | Year |
|---|---|
Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.
Topics: Acid Phosphatase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Captopril; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Isoenzymes; Male; Mice; Mice, Inbred DBA; NF-kappa B; Osteocalcin; Osteoclasts; Random Allocation; Renin; Renin-Angiotensin System; RNA, Messenger; Streptozocin; Tartrate-Resistant Acid Phosphatase; Tibia; Transforming Growth Factor beta; Up-Regulation | 2014 |
[Activation of osteoclasts by RAAS and strategy of target therapy on bone metabolic diseases].
Topics: Angiotensin II; Animals; Blood Pressure; Bone Diseases, Metabolic; Humans; Osteoclasts; Renin-Angiotensin System; Signal Transduction | 2012 |